Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2016
Plasmid-mediated quinolone resistance: Two decades on.
СтатьяОбзорПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rodríguez-Martínez José Manuel, Machuca Jesús, Cano María Eliecer, Calvo Jorge, Martínez-Martínez Luis, Pascual Alvaro
Аннотация
After two decades of the discovery of plasmid-mediated quinolone resistance (PMQR), three different mechanisms have been associated to this phenomenon: target protection (Qnr proteins, including several families with multiple alleles), active efflux pumps (mainly QepA and OqxAB pumps) and drug modification [AAC(6')-Ib-cr acetyltransferase]. PMQR genes are usually associated with mobile or transposable elements on plasmids, and, in the case of qnr genes, are often incorporated into sul1-type integrons. PMQR has been found in clinical and environmental isolates around the world and appears to be spreading. Although the three PMQR mechanisms alone cause only low-level resistance to quinolones, they can complement other mechanisms of chromosomal resistance to reach clinical resistance level and facilitate the selection of higher-level resistance, raising a threat to the treatment of infections by microorganisms that host these mechanisms.
Предметные рубрики MeSH
AcetyltransferasesAnti-Bacterial AgentsBacterial InfectionsBacterial ProteinsChromosomes, BacterialDrug Resistance, BacterialEscherichia coli ProteinsGene Expression Regulation, BacterialGram-Negative BacteriaGram-Positive BacteriaHumansMicrobial Sensitivity TestsPlasmidsProtein IsoformsQuinolonesTreatment Failure